Karen Auditore‐Hargreaves

Construction and properties of new Lyt-congenic strains and anti-Lyt-2.2 and anti-Lyt-3.1 monoclonal antibodies

Paul Gottlieb, Ann Marshak‐Rothstein, Karen Auditore‐Hargreaves et al. · Immunogenetics · 1980 · 133 citations

Allergy, Pathogenesis, Immunology +7

Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.

Scott S. Graves, Erica Dearstyne, Yukang Lin et al. · PubMed · 2003 · 53 citations

Immunology, Immunoediting, Pathology +17

Lyt-2 and Lyt-3 alloantigens: precipitation with monoclonal and conventional antibodies and analysis on one- and two-dimensional polyacrylamide gels.

Edward B. Reilly, Karen Auditore‐Hargreaves, Ulf Hammerling et al. · The Journal of Immunology · 1980 · 34 citations · Full text

Phase-separation immunoassays.

Karen Auditore‐Hargreaves, Raymond L. Houghton, Nobuo Monji et al. · Clinical Chemistry · 1987 · 33 citations · Full text

Solid-phase-based Immunoassays, Polymer Chemistry, Solid Phase +15

Performance and cost-effectiveness of a dual rapid assay system for screening and confirmation of human immunodeficiency virus type 1 seropositivity

Freya Spielberg, C.M. Kabeya, Thomas C. Quinn et al. · Journal of Clinical Microbiology · 1990 · 32 citations · Full text

Point-of-care Testing, Viral Diagnostics, Immunology +20